Public Calendar: May 4-10, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 05/06/2025
Location: Washington, DC
Subject: American Hospital Association's Annual Membership Meeting; Speaker: FDA Priorities
FDA Participant/Group: GRACE GRAHAM;
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders
Event Date: 05/06/2025
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: GRACE GRAHAM;
Non FDA Participant/Group: Members of the American College of Rheumatology Executive Committee
Event Date: 05/06/2025
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: GRACE GRAHAM;
Non FDA Participant/Group: Members of the U.S. Israel Education Association (USIEA)
Event Date: 05/07/2025
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: GRACE GRAHAM;
Non FDA Participant/Group: Members of the PhRMA Board of Directors
Event Date: 05/09/2025
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: SANJULA JAIN; KYLE DIAMANTAS;
Non FDA Participant/Group: Mara Burr, Melissa Hockstad, Rhonda Bentz, Sarah Gallo, Stacy Papadopoulos (Consumer Brands Association);
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods
Event Date: 05/05/2025
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: DONALD PRATER; LARRY MORRIS; ERIK METTLER; CONRAD CHOINIERE;
Non FDA Participant/Group: David Dyjack, Doug Farquhar, Rance Baker (National Environmental Health Association);
Event Date: 05/08/2025
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: MATTHEW BAKER; DONALD PRATER; LARRY MORRIS;
Non FDA Participant/Group: Cartier Esham (Esham Strategies); Mary Moody Johnson (SL Strategies);
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Vinayak Prasad, M.D.. M.P.H., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research
Event Date: 05/06/2025
Location: Rockville, MD
Subject: 2025 U.S. Pharmacopeia (USP) Convention Meeting; Regulators Forum Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders
Official Name: Timothy Schell. Ph.D., Acting Director, Center for Veterinary Medicine
No Significant Event